1130OResponses and durability of clinical benefit in renal...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1130OResponses and durability of clinical benefit in renal cell carcinoma treated with pegilodecakin in combination with anti-PD-1 inhibitors

Tannir, N M, Naing, A, Papadopoulos, K P, Wong, D J, Korn, W M, Aljumaily, R, Autio, K A, Pant, S, Bauer, T M, Drakaki, A, Daver, N, Hung, A, Oft, M, Leveque, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy288.003
Date:
October, 2018
File:
PDF, 81 KB
english, 2018
Conversion to is in progress
Conversion to is failed